tiprankstipranks
Trending News
More News >
Marksans Pharma Limited (IN:MARKSANS)
:MARKSANS
India Market

Marksans Pharma Limited (MARKSANS) Income Statement

Compare
2 Followers

Marksans Pharma Limited Income Statement

Last quarter (Q1 2024), Marksans Pharma Limited's total revenue was ₹5.91B, an increase of 18.12% from the same quarter last year. In Q1, Marksans Pharma Limited's net income was ₹887.52M. See Marksans Pharma Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
₹ 21.77B₹ 18.52B₹ 14.80B₹ 13.68B₹ 11.29B
Gross Profit
₹ 10.83B₹ 9.31B₹ 7.32B₹ 7.50B₹ 5.61B
Operating Expenses
₹ 3.29B₹ 6.43B₹ 5.15B₹ 4.31B₹ 3.95B
Depreciation and Amortization
₹ 742.70M₹ 518.53M₹ 447.76M₹ 361.51M₹ 266.62M
EBITDA
₹ 5.09B₹ 3.99B₹ 3.01B₹ 3.46B₹ 1.93B
Operating Income
₹ 7.79B₹ 2.88B₹ 2.14B₹ 3.09B₹ 1.70B
Other Income/Expenses
₹ -3.56B₹ -3.06B₹ -2.69B₹ 34.78M₹ -46.11M
Pretax Income
₹ 4.24B₹ 3.38B₹ 2.48B₹ 3.02B₹ 1.57B
Net Income
₹ 3.14B₹ 2.66B₹ 1.85B₹ 2.39B₹ 1.21B
Per Share Metrics
Basic EPS
₹ 6.92₹ 6.41₹ 4.51₹ 5.76₹ 2.86
Diluted EPS
₹ 6.92₹ 6.41₹ 4.51₹ 5.76₹ 2.86
Weighted Average Shares Outstanding
453.32M 415.40M 409.31M 409.31M 409.31M
Weighted Average Shares Outstanding (Diluted)
453.16M 415.40M 409.31M 409.31M 409.31M
Currency in INR

Marksans Pharma Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis